Personalized support everystep of the way

Personalizedsupport everystep of the way

Colton, 8 years old

Taking YUVIWEL as part of a clinical trial since age 2

The Ascendis Signature Access Program (A•S•A•P) provides ongoing assistance throughout your treatment journey.*
*A•S•A•P helps provide patient support services to eligible patients who have been prescribed YUVIWEL for its approved indication.

Through A•S•A•P, a Patient Access Liaison (PAL) can answer questions and provide support along the way:

Coverage icon
Helps you understand your insurance coverage, benefits, and financial support options
injection training icon
Provides injection training support
Information icon
Provides information about achondroplasia and how YUVIWEL can fit into your child's treatment plan

With A·S·A·P, you are never far from support.
Your PAL is someone you can reach out to for questions, information, and help along the way.

Connect now Connect now

Financial support

Eligible patients with commercial health insurance may pay as little as $0 per month for YUVIWEL.†

†Eligibility required. Federal and state healthcare beneficiaries are ineligible (participants in programs such as Medicaid, Medicare, Medigap, VA, DOD, or TRICARE). Offer not valid for cash-paying patients. Terms and conditions apply. For full terms and conditions and eligibility criteria, click here.

If you do not have insurance or are underinsured, you may qualify for treatment at $0 through the Ascendis Patient Assistance Program (PAP).‡

‡For full terms and conditions and eligibility criteria, click here.

Questions about A·S·A·P?

Talk to a member of our support team at 1-844-442-7236 (available from 8 AM to 8 PM ET, Monday through Friday). Select your language, then press 3 for YUVIWEL.

A.S.A.P questions icon
A.S.A.P SMS icon
Enroll in the program by completing the A•S·A·P consent form. icon Consent to enroll

Connect with a PAL and register for updates

A Patient Access Liaison (PAL) can provide you with individualized support and education about achondroplasia and treatment with YUVIWEL. Fill out the form below to receive important information about YUVIWEL and connect with a PAL.

*Required field.

Connect With a PAL

By checking this box, I confirm that I would like an Ascendis Patient Access Liaison to contact me with information about achondroplasia. I understand the PAL is not providing me medical advice and is not part of my healthcare team. I further certify that I am a resident of the United States and 18 years or older.

A PAL will reach out to you via phone.

Marketing Communications

By checking this box, I am agreeing to receive marketing communications from Ascendis Pharma and its service providers or partners, such as newsletters and updates, and to allow them to contact me for my opinion regarding products, programs, and services.

I understand that at any time I may unsubscribe by clicking on the designated link in the material.

Privacy Consent, Privacy Notice, and Terms of Use

By checking this box, I give my consent to the collection and processing of the personal and/or sensitive information requested above for the purposes I selected above. I understand that the information will be handled in accordance with the Ascendis Pharma Privacy Policy and Terms of Use. I understand that I may withdraw my consent at any time by contacting Ascendis at DataPrivacy@ascendispharma.com.

What is YUVIWEL?
YUVIWEL is a prescription medicine used to increase linear growth in children 2 years and older with achondroplasia with open growth plates (epiphyses).

YUVIWEL is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials.

USE AND IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

What are the possible side effects of YUVIWEL?
YUVIWEL may cause serious side effects, including risk of low blood pressure. If your child experiences a decrease in blood pressure or symptoms of low blood pressure (dizziness, feeling tired, and/or nausea) while being treated with YUVIWEL, call your child’s healthcare provider.

The most common side effects of YUVIWEL include injection site

What is YUVIWEL?
YUVIWEL is a prescription medicine used to increase linear growth in children 2 years and older with achondroplasia with open growth plates (epiphyses).

YUVIWEL is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials.

USE AND IMPORTANT SAFETY INFORMATION

What is YUVIWEL?
YUVIWEL is a prescription medicine used to increase linear growth in children 2 years and older with achondroplasia with open growth plates (epiphyses).

YUVIWEL is approved under accelerated approval based on an improvement in annualized growth velocity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials.

IMPORTANT SAFETY INFORMATION

What are the possible side effects of YUVIWEL?

YUVIWEL may cause serious side effects, including risk of low blood pressure. If your child experiences a decrease in blood pressure or symptoms of low blood pressure (dizziness, feeling tired, and/or nausea) while being treated with YUVIWEL, call your child’s healthcare provider.

The most common side effects of YUVIWEL include injection site reactions (redness, itching, skin discoloration, bleeding, swelling, bruising, pain, and blistering).

Before you give YUVIWEL to your child, tell the healthcare provider about all of your child’s medical conditions, including if they:

  • have kidney problems
  • are pregnant or plan to become pregnant. It is not known if YUVIWEL will harm the unborn baby
  • are breastfeeding or plan to breastfeed. It is not known if YUVIWEL passes into breast milk

Tell the healthcare provider about all the medicines your child takes, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

These are not all of the possible side effects of YUVIWEL. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch. You may also report side effects to Ascendis Pharma at 1-844-442-7236.

Please see the full Prescribing Information and Patient Information for YUVIWEL.

DOD=Department of Defense; VA=Veterans Affairs.